Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 213,670 | 235,848 | 249,539 | 213,613 | 200,221 |
| Cost of Goods | 48,815 | 50,184 | 52,445 | 38,553 | 39,257 |
| Gross Profit | 164,855 | 185,664 | 197,094 | 175,060 | 160,964 |
| Operating Expenses | 164,446 | 169,130 | 181,868 | 167,403 | 145,620 |
| Operating Income | 1,224 | 16,718 | 15,671 | 8,210 | 15,601 |
| Interest Expense | 49 | 259 | 411 | 129 | 49 |
| Other Income | 619 | 2,358 | 1,479 | 2,348 | 3,056 |
| Pre-tax Income | 1,794 | 18,817 | 16,739 | 10,429 | 18,608 |
| Income Tax | 8,456 | 8,373 | 7,449 | 5,945 | 8,001 |
| Net Income Continuous | -6,662 | 10,444 | 9,290 | 4,484 | 10,607 |
| Minority Interests | -140 | 789 | -112 | N/A | N/A |
| Net Income | $-6,522 | $9,655 | $9,402 | $4,454 | $10,607 |
| EPS Basic Total Ops | -0.36 | 0.52 | 0.49 | 0.23 | 0.56 |
| EPS Basic Continuous Ops | -0.36 | 0.56 | 0.49 | 0.24 | 0.56 |
| EPS Diluted Total Ops | -0.36 | 0.52 | 0.49 | 0.23 | 0.56 |
| EPS Diluted Continuous Ops | -0.36 | 0.56 | 0.49 | 0.24 | 0.56 |
| EPS Diluted Before Non-Recurring Items | -0.15 | 0.74 | 0.73 | 0.64 | 0.56 |
| EBITDA(a) | $10,791 | $26,322 | $25,916 | $14,094 | $21,160 |